Fecal microbiota transplantation improves hepatic steatosis induced by HFD in a mouse model associated with liver ILC1 regulation and indole-3-carbinol level

BackgroundThe prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has increased worldwide. In recent years, fecal microbiota transplantation (FMT) has become an important promising method for the treatment of MASLD. However, the mechanism remains unclear.MethodsThe animal...

Full description

Saved in:
Bibliographic Details
Main Authors: Peng-fei Hou, Yu Yao, Ying Wu, Hong-tao Yu, Yu Qin, Long Yi, Man-tian Mi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2025.1500293/full
Tags: Add Tag
No Tags, Be the first to tag this record!